A meta-analysis of the pros and cons of partial superficial parotidectomy versus superficial parotidectomy for the treatment of benign parotid neoplasms.

Meta-analysis Parotid gland benign tumor Parotid gland surgery Partial superficial parotidectomy Superficial parotidectomy

Journal

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
ISSN: 1878-4119
Titre abrégé: J Craniomaxillofac Surg
Pays: Scotland
ID NLM: 8704309

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 22 12 2019
revised: 10 03 2020
accepted: 07 04 2020
pubmed: 5 5 2020
medline: 18 9 2020
entrez: 5 5 2020
Statut: ppublish

Résumé

Salivary gland tumors are predominantly benign and frequently localized in the parotid gland (P). The treatment consists primarily of surgical removal; however, the appropriate extent remains a subject of debate. In suitable tumors, superficial parotidectomy (SP) may be substituted for less invasive partial superficial parotidectomy (PSP) (I C). This systematic review analyzed the available literature, comparing PSP and SP with regards to several postoperative outcome parameters (O). Established medical databanks were screened for articles evaluating outcomes of PSP compared with SP, published between 1955 and 2019. These data were assessed by pooled risk and odds ratios via meta-analysis. 11 studies with 1272 patients were included. There was no significant difference in tumor recurrence between PSP and SP (primary outcome). Furthermore, no differences in the occurrence of permanent facial nerve paralysis (FNP), salivary fistula, great auricular nerve analgesia, or hematoma were observed between the groups. However, PSP displayed significantly reduced rates of transient FNP, Frey's syndrome, scar deformity, and xerostomia, as well as shorter surgical time, compared with SP (secondary outcomes). Based on these data, PSP can be recommended as a surgical technique for the treatment of superficially located, small, benign parotid tumors.

Identifiants

pubmed: 32362539
pii: S1010-5182(20)30095-0
doi: 10.1016/j.jcms.2020.04.002
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

590-598

Informations de copyright

Copyright © 2020 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Chenxi Li (C)

Department of Oral and Maxillofacial Surgery, Laboratory for Tumor Genetics and Regenerative Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg 20246, Germany.

Levi Matthies (L)

Department of Oral and Maxillofacial Surgery, Laboratory for Tumor Genetics and Regenerative Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg 20246, Germany. Electronic address: l.matthies@uke.de.

Xinshan Hou (X)

The Oral Medicine Clinical Center, The First Affiliated Hospital of Xinjiang Medical University, Stomatology School of Xinjiang Medical University, Stomatology Research Institute of Xinjiang Province, Urumqi 830054, PR China.

Christian Knipfer (C)

Department of Oral and Maxillofacial Surgery, Laboratory for Tumor Genetics and Regenerative Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg 20246, Germany.

Martin Gosau (M)

Department of Oral and Maxillofacial Surgery, Laboratory for Tumor Genetics and Regenerative Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg 20246, Germany.

Reinhard E Friedrich (RE)

Department of Oral and Maxillofacial Surgery, Laboratory for Tumor Genetics and Regenerative Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg 20246, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH